2nd Enhancing Drug Bioavailability & Solubility 2013 is a conference that covers topics such as:
- Maximizing exposure for new compounds in early formulation development
- Pharmaceutical formulation development strategies for successful product development
- Expediting iime-to-market and reducing time-to-launch with physicochemical optimization
- Product diversification and enhancement through pre-formulation technologies
- Examining if cocrystal solubility in biorelevant media can be predicted
- Solution behavior of amorphous solid dispersions and their bioavailability implications
- Characterization, design and development of super saturation based drug delivery
- Expedited formulation development guided by biopharmaceutical modeling
- Solubilization approaches for parenteral routes of administration
2nd Enhancing Drug Bioavailability & Solubility 2013 brings together pharmaceutical, biotech and academic professionals specializing in Pre-Formulation, Formulation, Preclinical / Analytical Development, Medicinal / Analytical / Solid state Chemistry, Drug Discovery, Drug Delivery, Partnering, Licensing & Alliance Management, Life-Cycle / Portfolio Management, Product Enhancement / Development, Intellectual Property, Pharmaceutics, Toxicology, Chemical Engineering, Physiochemistry and Process R&D.
